Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Pharmaceutical industry experts have also expressed ... This is, however, subject to the definition of high-income countries. “Since references will be set for the prices of medicines in ...

Claude 4’s “whistle-blow” surprise shows why agentic AI risk lives in prompts and tool access, not benchmarks. Learn the 6 ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

Alma, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launched ...

Thanks to GLP-1 drugs like Ozempic and Wegovy, we're entering a new phase where people are eating less but expecting more ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Audits of the non-surgical cosmetics industry are under way to check compliance with legislation at both state and federal ...

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity ...

It’s been a rocky start to 2025, so we gathered five banking experts to talk about what they are seeing from the economy and ...

High inflation has seen a reduction in the real value of wage rates — so while it’s good news the Fair Work Commission ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The ...